Boothbay Fund Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.6M | Buy |
+502,000
| New | +$3.6M | 0.07% | 255 |
|
|
2022
Q4 | – | Sell |
-19,752
| Closed | -$295K | – | 1794 |
|
|
2022
Q3 | $295K | Sell |
19,752
-13,748
| -41% | -$205K | 0.01% | 1320 |
|
|
2022
Q2 | $302K | Buy |
+33,500
| New | +$302K | 0.01% | 1258 |
|
|
2021
Q2 | – | Sell |
-11,109
| Closed | -$98K | – | 1711 |
|
|
2021
Q1 | $98K | Buy |
+11,109
| New | +$98K | ﹤0.01% | 1239 |
|